Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10,420.00 GBX | +0.27% |
|
-3.68% | -0.46% |
06-02 | ASTRAZENECA : Buy rating from JP Morgan | ZD |
06-02 | UK's FTSE 100 closes around flat as staples, healthcare losses eclipse energy gains | RE |
Chart calendar AstraZeneca PLC
0957.Y5JIMHEObvlACXZKlfHeTtK_WPy1iciPsvSM3T2K-qI.E-EmfDAjBbIaWh8l48LuNpbqL6vA04Te46T7tny7rdtX3x59SXYUnSlgEQ~fceac42d00d9ae167a3f9148b66bf0d2
Upcoming events on AstraZeneca PLC
Past events on AstraZeneca PLC
Past dividends on AstraZeneca PLC
19/02/2025 | Final Payment 1.68 GBP |
07/08/2024 | Interim Payment 0.776 GBP |
21/02/2024 | Final Payment 1.56 GBP |
09/08/2023 | Interim Payment 0.718 GBP |
22/02/2023 | Final Payment 1.628 GBP |
10/08/2022 | Interim Payment 0.764 GBP |
23/02/2022 | Final Payment 1.453 GBP |
11/08/2021 | Interim Payment 0.648 GBP |
24/02/2021 | Final Payment 1.374 GBP |
12/08/2020 | Interim Payment 0.696 GBP |
26/02/2020 | Final Payment 1.464 GBP |
07/08/2019 | Interim Payment 0.719 GBP |
27/02/2019 | Final Payment 1.468 GBP |
08/08/2018 | Interim Payment 0.684 GBP |
14/02/2018 | Final Payment 1.336 GBP |
09/08/2017 | Interim Payment 0.689 GBP |
15/02/2017 | Final Payment 1.502 GBP |
10/08/2016 | Interim Payment 0.687 GBP |
17/02/2016 | Final Payment 1.31 GBP |
12/08/2015 | Interim Payment 0.575 GBP |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 44 351 44 465 -0.26% | 45 811 45 716 0.21% | 54 073 53 340 1.37% | 57 830 | 61 182 | 64 582 |
EBITDA Million USD | Released Forecast Spread | 9 237 13 681 -32.49% | 13 580 15 477 -12.26% | 16 691 16 909 -1.29% | 19 647 | 22 555 | 24 743 |
EBIT Million USD | Released Forecast Spread | 13 350 13 702 -2.57% | 14 534 15 036 -3.34% | 16 928 17 034 -0.63% | 18 538 | 20 755 | 22 887 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 501 3 511 -28.78% | 6 899 9 269 -25.57% | 8 691 10 318 -15.77% | 12 702 | 15 295 | 17 211 |
Net income Million USD | Released Forecast Spread | 3 288 4 262 -22.86% | 5 961 6 597 -9.64% | 7 035 8 172 -13.91% | 9 919 | 11 947 | 13 392 |
EPS USD | Released Forecast Spread | 2,11 2,81 -24.96% | 3,81 4,34 -12.22% | 4,50 5,33 -15.6% | 6,38 | 7,69 | 8,77 |
Announcement Date | 09/02/23 | 08/02/24 | 06/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 492 11 529 -0.32% | 12 024 12 007 0.14% | 12 679 11 812 7.34% | 12 938 12 528 3.28% | 25 617 12 560 103.96% | 13 565 13 102 3.53% | 14 891 14 181 5.01% | 13 588 13 741 -1.11% | 14 080 | 14 571 | 15 307 | 14 320 | 14 600 | 15 240 | 15 950 |
EBITDA Million USD | Released Forecast Spread | 4 025 4 305 -6.51% | 3 923 4 265 -8.01% | 4 373 5 435 -19.54% | 4 958 5 324 -6.87% | 4 424 | 4 743 | 4 424 | ||||||||
EBIT Million USD | Released Forecast Spread | 3 545 3 537 0.24% | 2 752 3 206 -14.15% | 4 310 3 911 10.2% | 4 101 4 016 2.11% | 8 411 4 052 107.58% | 4 318 4 177 3.37% | 4 199 4 300 -2.34% | 4 803 4 583 4.81% | 4 544 | 4 549 | 4 415 | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 652 2 510 -34.17% | 897 1 671 -46.32% | 2 800 2 296 21.95% | 2 397 2 395 0.08% | 1 828 2 873 -36.37% | 1 666 2 825 -41.03% | |||||||||
Net income Million USD | Released Forecast Spread | 1 378 1 705 -19.16% | 959 2 313 -58.53% | 2 179 2 065 5.52% | 1 927 2 130 -9.52% | 1 429 2 332 -38.72% | 1 500 3 284 -54.32% | 2 916 2 458 18.63% | 2 517 | 2 687 | 2 273 | |||||
EPS USD | Released Forecast Spread | 0,89 1,09 -18.64% | 0,62 1,49 -58.3% | 1,41 1,33 6.28% | 1,24 1,36 -9% | 0,91 1,49 -39.13% | 0,96 2,11 -54.44% | 1,88 1,57 19.47% | 1,61 | 1,72 | 1,46 | |||||
Announcement Date | 09/11/23 | 08/02/24 | 25/04/24 | 25/07/24 | 25/07/24 | 12/11/24 | 06/02/25 | 29/04/25 | - | - | - | - | - | - | - |
More events
Past sector events for AstraZeneca PLC
17/06/2025 16:45 | MEDINCELL S.A.: Q4 2025 Earnings Release |
10/06/2025 09:38 | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
09/06/2025 09:48 | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
09/06/2025 01:01 | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
06/06/2025 09:47 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
05/06/2025 09:37 | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
03/06/2025 09:35 | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
30/05/2025 14:46 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
29/05/2025 12:00 | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
29/05/2025 09:31 | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZN Stock
- Calendar AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition